More than two million Americans will suffer a traumatic brain injury in 2026. TBI is one of the leading causes of death and ...

Researchers identified the earliest case of a genetic disease with the help of DNA: ...

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

One of the first Australians to receive the groundbreaking treatment says it has helped restore clarity, as access and cost ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

Retreatment with venetoclax and rituximab in CLL patients achieved 100% response rates and prolonged progression-free ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

The disease leads to the progressive growth of fluid-filled cysts in the kidneys, often resulting in kidney failure and other ...

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

Your Monthly Dose of Good News: - 300,000 landmines removed in Sri Lanka - Mexico enacts new law to protect sharks - North ...

Emerging data investigate MRI brain screening for metastatic breast cancer patients. Duke Cancer Center's Carey Anders, MD, along with other leading medical experts, discusses the need for women to ...